Submit Deal

Submit Deal

Cover Image Daniel R. Omstead

Daniel R. Omstead

President and CEO at TEKLA CAPITAL MANAGEMENT LLC

Investor

Deal Bio

Total Deals12

Valued Deals11

Total Value£ 1.09 B

Avg. Deal Size£ 99 M

Market Context

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Daniel R. Omstead

Sort

19 May 2020|United States|Pharmaceuticals

Target: RALLYBIO

Bidder: PIVOTAL BIOVENTURE PARTNERS LLC

14 Service Providers

2 Target | 12 Bidder

28 Dealmakers

3 Target | 25 Bidder

£ 119 M

Value

15 Oct 2020|Switzerland|Biotechnology

Target: VECTIVBIO

Bidder: CORMORANT ASSET MANAGEMENT

16 Service Providers

3 Target | 13 Bidder

35 Dealmakers

16 Target | 21 Bidder

£ 84 M

Value

02 Apr 2020|France|Biotechnology

Target: DYNACURE

Bidder: KURMA PARTNERS

9 Service Providers

3 Target | 6 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 41 M

Value

04 May 2021|Switzerland|Pharmaceuticals

Target: OCULIS

Bidder: TEKLA CAPITAL MANAGEMENT LLC

13 Service Providers

2 Target | 11 Bidder

18 Dealmakers

5 Target | 13 Bidder

£ 40 M

Value

04 Oct 2021|Switzerland|Biotechnology

Target: MOONLAKE IMMUNOTHERAPEUTICS

Bidder: BVF PARTNERS

25 Service Providers

7 Target | 18 Bidder

44 Dealmakers

11 Target | 34 Bidder

£ 169 M

Value

29 Nov 2021|United States|Biotechnology

Target: HOTSPOT THERAPEUTICS

Bidder: SOFINNOVA PARTNERS

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

07 Feb 2022|United States|Biotechnology

Target: ENDEAVOR BIOMEDICINES

Bidder: ALLY BRIDGE GROUP

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

10 May 2022|United States|Pharmaceuticals

Target: INVETX

Bidder: F-PRIME CAPITAL

10 Service Providers

3 Target | 7 Bidder

13 Dealmakers

6 Target | 7 Bidder

£ 49 M

Value

17 Oct 2022|Switzerland|Pharmaceuticals

Target: OCULIS

Bidder: TEKLA CAPITAL MANAGEMENT LLC

22 Service Providers

7 Target | 15 Bidder

25 Dealmakers

8 Target | 17 Bidder

£ 194 M

Value

06 Jan 2023|France|Biotechnology

Target: AMOLYT PHARMA

Bidder: TEKLA CAPITAL MANAGEMENT LLC

17 Service Providers

3 Target | 14 Bidder

18 Dealmakers

4 Target | 14 Bidder

£ 115 M

Value

20 Jun 2023|United States|Private Equity

Target: TEKLA CAPITAL MANAGEMENT (HEALTHCARE FUND MANAGEMENT CAPABILITIES)

Bidder: ABRDN PLC (EX-STANDARD LIFE ABERDEEN)

3 Service Providers

2 Bidder | 1 Vendor

23 Dealmakers

22 Bidder | 1 Vendor

n/a

Value

11 Aug 2023|United States|Biotechnology

Target: ABCURO

Bidder: REDMILE GROUP

15 Service Providers

3 Target | 12 Bidder

17 Dealmakers

4 Target | 13 Bidder

£ 121 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy